Evidence map›Paper›PMID 1651496›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1991

Double targeted gene replacement for creating null mutants.

A Cruz, C M Coburn, S M Beverley

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1991. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 322 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in immunology · 2024
    Article
  4. Impact of Genetic Diversity and Genome Plasticity ofFrontiers in cellular and infection microbiology · 2022
    Review
  5. Genome deletions to overcome the directed loss of gene function inFrontiers in cellular and infection microbiology · 2022
    Article
  6. InInternational journal of molecular sciences · 2021
    Article
  7. Article
  8. Article
  9. Deletion of Glutamine Synthetase Gene Disrupts the Survivability and Infectivity ofFrontiers in cellular and infection microbiology · 2021
    Article
  10. Frontiers in cellular and infection microbiology · 2021
    Article
  11. LmjF.22.0810 fromBiomedicines · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Computational and structural biotechnology journal · 2020
    Review
  17. Frontiers in cellular and infection microbiology · 2020
    Article
  18. Application of CRISPR/Cas9-Mediated Genome Editing in Leishmania.Methods in molecular biology (Clifton, N.J.) · 2020
    Article
  19. Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

A CruzDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.
C M Coburn
S M Beverley
Harvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have used double gene targeting to create homozygous gene replacements in the protozoan parasite Leishmania major, an asexual diploid. This method uses two independent selectable markers in successive rounds of gene targeting to replace both alleles of an endogenous gene. We developed an improved hygromycin B-resistance cassette encoding hygromycin phosphotransferase (HYG) for use as a selectable marker for Leishmania. HYG-containing vectors functioned equivalently to those containing the neomycin phosphotransferase (NEO) cassette previously used for extrachromosomal transformation or gene targeting. Drug resistances conferred by the NEO and HYG markers were independent, allowing simultaneous selection for both markers. A HYG targeting vector was utilized to replace the single dihydrofolate reductase-thymidylate synthase (DHFR-TS) gene remaining in a line heterozygous for a NEO replacement at the dhfr-ts locus (+/neo), with a targeting efficiency comparable to that seen with wild-type recipients. The resultant dhfr-ts- line (hyg/neo) was auxotrophic for thymidine. The double targeted replacement method will enable functional genetic testing in a variety of asexual diploids, including cultured mammalian cells and fungi such as Candida albicans. Additionally, it may be possible to use Leishmania bearing conditionally auxotrophic gene replacements as safe, improved live vaccines for leishmaniasis.

Indexed as

Genetic EngineeringMutagenesis, InsertionalPhosphotransferases (Alcohol Group Acceptor)AllelesAnimalsBase SequenceBlotting, SouthernCell LineDiploidyGenetic MarkersKanamycin KinaseKaryotypingLeishmania tropicaMolecular Sequence DataOligonucleotide ProbesPhosphotransferasesGenetic Markershygromycin-B kinaseKanamycin KinaseOligonucleotide ProbesPhosphotransferasesPhosphotransferases (Alcohol Group Acceptor)Tetrahydrofolate DehydrogenaseThymidylate Synthase

Identifiers

PMID1651496
PMCPMC52255
OpenAlexW2072607746

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.